mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.055 |
0.3 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.3 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |